Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Lancet Diabetes Endocrinol. 2013 Dec 23;2(8):655–666. doi: 10.1016/S2213-8587(13)70191-8

Table 3.

Treatment strategies for hypertriglyceridaemia by triglyceride concentration

Moderately high (2–9·9 mmol/L) High (≥10 mmol/L)
Treatment priority Prevent cardiovascular disease Prevent acute pancreatitis
Primary therapeutic goal Achieve LDL cholesterol target Reduce triglyceride concentrations
Secondary therapeutic goals Achieve non-HDL cholesterol target, which is 0·8 mmol/L higher than LDL cholesterol goal, or APOB concentration <0·8 g/L; rule out and treat secondary factors Goals: achieve LDL cholesterol and non-HDL cholesterol goals once pancreatitis risk is decreased, as described above; rule out and treat secondary factors
Non-pharmacological therapeutic strategies Reduce bodyweight, reduce alcohol intake, reduce simple sugar intake, increase aerobic activity, reduce total carbohydrate intake, replace trans and saturated fats with monounsaturated fats, increase dietary omega-3 fatty acids Eliminate oral intake during acute pancreatitis with intravenous rehydration, then slowly re-introduce foods with small frequent meals, then longer-term strict fat-reduced diet (<20% of calories as fat), reduce bodyweight, reduce alcohol intake, reduce simple sugar intake, reduce total carbohydrate intake, replace trans and saturated fats with monounsaturated fats; increase dietary omega-3 fatty acids; increase aerobic activity
Pharmacological therapeutic strategies Statins if necessary to control LDL cholesterol; if LDL cholesterol is close to goal, titrate statin dose to achieve both LDL and non-HDL cholesterol targets; if LDL cholesterol is at goal, but non-HDL cholesterol is still high, titrate statin dose or add fibrate, nicotinic acid, or omega-3 fatty acids Consider fibrate, nicotinic acid, and omega-3 fatty acids